Author's Reply to Srinivas: "Modeling the Relationship Between Exposure to Abiraterone and Prostate-Specific Antigen Dynamics in Patients with Metastatic Castration-Resistant Prostate Cancer".
Janssen Research & Development, 920 Route 202, Raritan, NJ, 08869, USA. SXu26@its.jnj.com.
Steven
S
Xu
Janssen Research & Development, Beerse, Belgium.
Peter
P
De Porre
D000069501:Abiraterone Acetate; D000736:Androstenes; D006801:Humans; D008297:Male; D017430:Prostate-Specific Antigen; D064129:Prostatic Neoplasms, Castration-Resistant
D000736:Androstenes; D017430:Prostate-Specific Antigen; D000069501:Abiraterone Acetate; C089740:abiraterone